Sivelestat significantly reduced the incidence of postoperative acute respiratory distress syndrome (ARDS) compared to placebo in adult patients undergoing cardiac surgery requiring cardiopulmonary ...

Although perioperative prophylactic glucocorticoids have been used for decades, whether they improve outcomes in infants after heart surgery with cardiopulmonary bypass is unknown. We conducted a ...

Even as the federal government prepares to cut off funding to Baylor St. Luke’s Medical Center’s poorly performing heart transplant program, the Houston hospital has continued to promote itself as a ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

Please provide your email address to receive an email when new articles are posted on . Elevated serum cardiac troponin I level can potentially be used as a stand-alone marker to predict adverse ...

Levels of a biomarker used in the diagnosis of heart attacks are almost universally elevated in patients who have undergone coronary-artery bypass grafting (CABG) and, when markedly elevated, ...

DURHAM, N.C. – A drug designed to shield the heart from injury during bypass surgery failed to reduce deaths, strokes and other serious events among patients at high risk of complications, according ...